These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26265188)

  • 41. Prediction of Optimum Combination of Eudragit RS/Eudragit RL/Ethyl Cellulose Polymeric Free Films Based on Experimental Design for Using as a Coating System for Sustained Release Theophylline Pellets.
    Akhgari A; Tavakol A
    Adv Pharm Bull; 2016 Jun; 6(2):219-25. PubMed ID: 27478784
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A pH dependent delivery of mesalazine from polymer coated and drug-loaded SBA-16 systems.
    Trendafilova I; Szegedi Á; Yoncheva K; Shestakova P; Mihály J; Ristić A; Konstantinov S; Popova M
    Eur J Pharm Sci; 2016 Jan; 81():75-81. PubMed ID: 26453768
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Eudragit L/HPMCAS blend enteric-coated lansoprazole pellets: enhanced drug stability and oral bioavailability.
    Fang Y; Wang G; Zhang R; Liu Z; Liu Z; Wu X; Cao D
    AAPS PharmSciTech; 2014 Jun; 15(3):513-21. PubMed ID: 24590548
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physical and chemical factors influencing the release of drugs from acrylic resin films.
    Jenquin MR; Liebowitz SM; Sarabia RE; McGinity JW
    J Pharm Sci; 1990 Sep; 79(9):811-6. PubMed ID: 2273466
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An organic acid-induced sigmoidal release system for oral controlled-release preparations. 2. Permeability enhancement of Eudragit RS coating led by the physicochemical interactions with organic acid.
    Narisawa S; Nagata M; Hirakawa Y; Kobayashi M; Yoshino H
    J Pharm Sci; 1996 Feb; 85(2):184-8. PubMed ID: 8683446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mechanistic investigations of phase behavior in Eudragit E blends.
    Menjoge AR; Kulkarni MG
    Int J Pharm; 2007 Oct; 343(1-2):106-21. PubMed ID: 17587518
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Physicochemical characterization and mechanisms of release of theophylline from melt-extruded dosage forms based on a methacrylic acid copolymer.
    Young CR; Dietzsch C; Cerea M; Farrell T; Fegely KA; Rajabi-Siahboomi A; McGinity JW
    Int J Pharm; 2005 Sep; 301(1-2):112-20. PubMed ID: 16055285
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Novel application method of talcum powder to prevent sticking tendency and modify release of esomeprazole magnesium enteric-coated pellets.
    Liu Z; Wang W; Chen H; Liu J; Zhang W
    Pharm Dev Technol; 2016; 21(4):405-14. PubMed ID: 25708151
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Basic coating polymers for the colon-specific drug delivery in inflammatory bowel disease.
    Leopold CS; Eikeler D
    Drug Dev Ind Pharm; 2000 Dec; 26(12):1239-46. PubMed ID: 11147124
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Polyvinyl acetate-based film coatings.
    Kolter K; Dashevsky A; Irfan M; Bodmeier R
    Int J Pharm; 2013 Dec; 457(2):470-9. PubMed ID: 24076229
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Use of poly(meth)acrylates for the control and release of pholedrine sulfate from microdragees].
    Hennig D; Kala H
    Pharmazie; 1985 Aug; 40(8):554-7. PubMed ID: 4080801
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Quaternary polymethacrylate-sodium alginate films: effect of alginate block structures and use for sustained release tablets.
    Pongjanyakul T; Khuathan N
    Pharm Dev Technol; 2016; 21(4):487-98. PubMed ID: 25757646
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Novel Salted Anionic-Cationic Polymethacrylate Polymer Blends for Sustained Release of Acidic and Basic Drugs.
    Obeidat WM; Qasim D; Nokhodchi A; Al-Jabery A; Sallam AS
    Curr Drug Deliv; 2017; 14(1):109-122. PubMed ID: 27138298
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Polymer blends used for the coating of multiparticulates: comparison of aqueous and organic coating techniques.
    Lecomte F; Siepmann J; Walther M; MacRae RJ; Bodmeier R
    Pharm Res; 2004 May; 21(5):882-90. PubMed ID: 15180349
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural transformations during swelling of polycomplex matrices based on countercharged (meth)acrylate copolymers (Eudragit EPO/Eudragit L 100-55).
    Moustafine RI; Bobyleva VL; Bukhovets AV; Garipova VR; Kabanova TV; Kemenova VA; Van Den Mooter G
    J Pharm Sci; 2011 Mar; 100(3):874-85. PubMed ID: 20803617
    [TBL] [Abstract][Full Text] [Related]  

  • 56. In situ co-amorphisation in coated tablets - The combination of carvedilol with aspartic acid during immersion in an acidic medium.
    Petry I; Löbmann K; Grohganz H; Rades T; Leopold CS
    Int J Pharm; 2019 Mar; 558():357-366. PubMed ID: 30641182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of drug release from coated pellets based on isomalt, sugar, and microcrystalline cellulose inert cores.
    Kállai N; Luhn O; Dredán J; Kovács K; Lengyel M; Antal I
    AAPS PharmSciTech; 2010 Mar; 11(1):383-91. PubMed ID: 20237965
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Incorporation of polymeric nanoparticles into solid dosage forms.
    Schmidt C; Bodmeier R
    J Control Release; 1999 Feb; 57(2):115-25. PubMed ID: 9971890
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Formulation and in vitro evaluation of polymeric enteric nanoparticles as dermal carriers with pH-dependent targeting potential.
    Sahle FF; Balzus B; Gerecke C; Kleuser B; Bodmeier R
    Eur J Pharm Sci; 2016 Sep; 92():98-109. PubMed ID: 27393341
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Drug release modification by interpolymer interaction between countercharged types of Eudragit® RL 30D and FS 30D in double-layer films.
    Moustafine RI; Bodrov AV; Kemenova VA; Rombaut P; Van den Mooter G
    Int J Pharm; 2012 Dec; 439(1-2):17-21. PubMed ID: 23041129
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.